Results 41 to 50 of about 5,711,116 (385)

Abiraterone and increased survival in metastatic prostate cancer.

open access: yesNew England Journal of Medicine, 2011
BACKGROUND Biosynthesis of extragonadal androgen may contribute to the progression of castration-resistant prostate cancer. We evaluated whether abiraterone acetate, an inhibitor of androgen biosynthesis, prolongs overall survival among patients with ...
J. D. de Bono   +31 more
semanticscholar   +1 more source

Outcomes of Observation vs Stereotactic Ablative Radiation for Oligometastatic Prostate Cancer

open access: yesJAMA Oncology, 2020
This randomized clinical trial assesses whether treatment with stereotactic ablative radiotherapy vs observation improves oncologic outcomes in men with recurrent hormone-sensitive oligometastatic prostate cancer.
R. Phillips   +25 more
semanticscholar   +1 more source

Oncologic aspects of long-term followed incidental prostate cancer detected by cystoprostatectomy in Korean patients

open access: yesProstate International, 2015
Purpose: To determine the incidence and clinical features of incidentally discovered prostate adenocarcinoma in patients undergoing radical cystoprostatectomy (CPT) for bladder cancer.
In-Chang Cho   +7 more
doaj   +1 more source

Prostate cancer incidence in Golestan province, Iran (2004) [PDF]

open access: yes, 2008
Prostate cancer is the most common cancer in men and therefore represents a major problem in public health.The aim of this study was to find and evaluate province-specific estimate of incidence in males by age groups for prostate cancer in Golestan ...
Kabir, M.J., Marjani, A.
core   +1 more source

How to turn up the heat on the cold immune microenvironment of metastatic prostate cancer

open access: yesProstate Cancer and Prostatic Diseases, 2021
Advanced prostate cancer remains one of the most common and deadly cancers, despite advances in treatment options. Immunotherapy has provided little benefit to a majority of patients, largely due to the immunosuppressive tumor microenvironment that gives
J. Stultz, L. Fong
semanticscholar   +1 more source

Hedgehog Signalling in Androgen Independent Prostate Cancer [PDF]

open access: yes, 2008
Objectives: Androgen-deprivation therapy effectively shrinks hormone-naïve prostate cancer, both in the prostate and at sites of distant metastasis.
Bisson, Isabelle   +7 more
core   +1 more source

Ferroptosis Inducers Are a Novel Therapeutic Approach for Advanced Prostate Cancer

open access: yesCancer Research, 2021
These findings reveal that induction of ferroptosis is a new therapeutic strategy for advanced prostate cancer as a monotherapy and in combination with second-generation antiandrogens.
A. Ghoochani   +8 more
semanticscholar   +1 more source

Dutasteride and Prostate Cancer [PDF]

open access: yesNew England Journal of Medicine, 2010
Contains fulltext : 88812.pdf (Publisher’s version ) (Open Access)
Kiemeney, L.A.L.M., Bosland, M.C.
openaire   +8 more sources

A microsatellite repeat in PCA3 long non-coding RNA is associated with prostate cancer risk and aggressiveness

open access: yesScientific Reports, 2017
Short tandem repeats (STRs) are repetitive sequences of a polymorphic stretch of two to six nucleotides. We hypothesized that STRs are associated with prostate cancer development and/or progression. We undertook RNA sequencing analysis of prostate tumors
John Lai   +13 more
doaj   +1 more source

SETD2, GIGYF2, FGFR3, BCR, KMT2C, and TSC2 as candidate genes for differentiating multilocular cystic renal neoplasm of low malignant potential from clear cell renal cell carcinoma with cystic change [PDF]

open access: yesInvestigative and Clinical Urology, 2019
Purpose: Multilocular cystic renal neoplasm of low malignant potential (MCRNLMP) and clear cell renal cell carcinoma with cystic change (MCRCC) have different prognoses despite similar histologic characteristics.
Sung Han Kim   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy